231 related articles for article (PubMed ID: 17196051)
1. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.
Frye MA; Yatham LN; Calabrese JR; Bowden CL; Ketter TA; Suppes T; Adams BE; Thompson TR
J Clin Psychiatry; 2006 Nov; 67(11):1721-8. PubMed ID: 17196051
[TBL] [Abstract][Full Text] [Related]
2. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
Goodwin GM; Bowden CL; Calabrese JR; Grunze H; Kasper S; White R; Greene P; Leadbetter R
J Clin Psychiatry; 2004 Mar; 65(3):432-41. PubMed ID: 15096085
[TBL] [Abstract][Full Text] [Related]
3. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
Calabrese JR; Goldberg JF; Ketter TA; Suppes T; Frye M; White R; DeVeaugh-Geiss A; Thompson TR
Biol Psychiatry; 2006 Jun; 59(11):1061-4. PubMed ID: 16769295
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
[TBL] [Abstract][Full Text] [Related]
6. Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.
Frye MA; Yatham L; Ketter TA; Goldberg J; Suppes T; Calabrese JR; Bowden CL; Bourne E; Bahn RS; Adams B
Acta Psychiatr Scand; 2009 Jul; 120(1):10-3. PubMed ID: 19183414
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine: a review of its use in bipolar disorder.
Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
Drugs; 2003; 63(19):2029-50. PubMed ID: 12962521
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).
Licht RW; Nielsen JN; Gram LF; Vestergaard P; Bendz H
Bipolar Disord; 2010 Aug; 12(5):483-93. PubMed ID: 20712749
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
Smith LA; Cornelius V; Warnock A; Bell A; Young AH
Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
[TBL] [Abstract][Full Text] [Related]
13. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
Calvert NW; Burch SP; Fu AZ; Reeves P; Thompson TR
J Manag Care Pharm; 2006 May; 12(4):322-30. PubMed ID: 16792438
[TBL] [Abstract][Full Text] [Related]
15. Spotlight on lamotrigine in bipolar disorder.
Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
[TBL] [Abstract][Full Text] [Related]
16. Risk of postpartum episodes in women with bipolar disorder after lamotrigine or lithium use during pregnancy: A population-based cohort study.
Wesseloo R; Liu X; Clark CT; Kushner SA; Munk-Olsen T; Bergink V
J Affect Disord; 2017 Aug; 218():394-397. PubMed ID: 28501739
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.
Oya K; Sakuma K; Esumi S; Hashimoto Y; Hatano M; Matsuda Y; Matsui Y; Miyake N; Nomura I; Okuya M; Iwata N; Kato M; Hashimoto R; Mishima K; Watanabe N; Kishi T
Neuropsychopharmacol Rep; 2019 Sep; 39(3):241-246. PubMed ID: 31026388
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
Maina G; Albert U; Rosso G; Bogetto F
J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
[TBL] [Abstract][Full Text] [Related]
19. Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder.
Sachs G; Bowden C; Calabrese JR; Ketter T; Thompson T; White R; Bentley B
Bipolar Disord; 2006 Apr; 8(2):175-81. PubMed ID: 16542188
[TBL] [Abstract][Full Text] [Related]
20. Latest maintenance data on lamotrigine in bipolar disorder.
Calabrese JR; Vieta E; Shelton MD
Eur Neuropsychopharmacol; 2003 Aug; 13 Suppl 2():S57-66. PubMed ID: 12957721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
